首页> The lancet oncology> Intensity-modulated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): 2-year toxicity results from an open-label, randomised, phase 3, non-inferiority trial

Intensity-modulated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): 2-year toxicity results from an open-label, randomised, phase 3, non-inferiority trial

导出原文传递

翻译打印收藏纠错

第一作者： Tree A.C.

作者： Tree A.C. ^[1] ; Ostler P. ^[2] ; van der Voet H. ^[3] ; Chu W. ^[4] ; Loblaw A. ^[5] ; Ford D. ^[6] ; Tolan S. ^[7] ; Jain S. ^[8] ; Martin A. ^[9] ; Staffurth J. ^[10] ; Armstrong J. ^[11] ; Camilleri P. ^[12] ; Kancherla K. ^[13] ; Frew J. ^[14] ; Chan A. ^[15] ; Dayes I.S. ^[16] ; Duffton A. ^[17] ; Brand D.H. ; Henderson D. ; Morrison K. ; Brown S. ; Pugh J. ; Burnett S. ; Mahmud M. ; Hinder V. ; Naismith O. ; Hall E. ; van As N. ; Lartigau E. ; Patton S. ; Thompson A. ; Winkler M. ; Wells P. ; Lymberiou T. ; Saunders D. ; Vilarino-Varela M. ; Vavassis P. ; Tsakiridis T. ; Carlson R. ; Rodrigues G. ; Tanguay J. ; Iqbal S. ; Morgan S. ; Mihai A. ; Li A. ; Din O. ; Panades M. ; Wade R. ; Rimmer Y. ; Oommen N.

作者单位： The Royal Marsden Hospital ^[1] Mount Vernon Cancer Centre ^[2] The James Cook University Hospital ^[3] Odette Cancer Centre Sunnybrook Health Sciences Centre ^[4] University Hospitals Birmingham ^[5] The Clatterbridge Cancer Centre ^[6] Queen's University Belfast ^[7] Cambridge University Hospitals NHS Foundation Trust ^[8] Cardiff University ^[9] Cancer Trials Ireland ^[10] Churchill Hospital ^[11] University Hospitals of Leicester ^[12] Freeman Hospital ^[13] University Hospitals Coventry & Warwickshire ^[14] Department of Oncology McMaster University ^[15] Beatson West of Scotland Cancer Centre ^[16] The Institute of Cancer Research ^[17]

发布时间 2023-01-08

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交